Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) EPS (Basic) (2020 - 2025)

NeuroPace has reported EPS (Basic) over the past 6 years, most recently at -$0.08 for Q4 2025.

  • Quarterly results put EPS (Basic) at -$0.08 for Q4 2025, up 52.94% from a year ago — trailing twelve months through Dec 2025 was -$0.66 (up 29.79% YoY), and the annual figure for FY2025 was -$0.66, up 29.03%.
  • EPS (Basic) for Q4 2025 was -$0.08 at NeuroPace, up from -$0.11 in the prior quarter.
  • Over the last five years, EPS (Basic) for NPCE hit a ceiling of -$0.08 in Q4 2025 and a floor of -$32.73 in Q1 2021.
  • Median EPS (Basic) over the past 5 years was -$0.33 (2021), compared with a mean of -$1.93.
  • Biggest five-year swings in EPS (Basic): soared 98.9% in 2021 and later plummeted 41.18% in 2022.
  • NeuroPace's EPS (Basic) stood at -$0.36 in 2021, then dropped by 22.22% to -$0.44 in 2022, then soared by 50.0% to -$0.22 in 2023, then grew by 22.73% to -$0.17 in 2024, then soared by 52.94% to -$0.08 in 2025.
  • The last three reported values for EPS (Basic) were -$0.08 (Q4 2025), -$0.11 (Q3 2025), and -$0.26 (Q2 2025) per Business Quant data.